Page 5 - Nasdaq Hrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq hrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Hrow Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Short Interest Up 6.8% in April

Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 2,210,000 shares, a growth of 6.8% from the March 31st total of 2,070,000 shares. Based on an average daily volume of 376,400 shares, the days-to-cover ratio is […] ....

Harrow Health Inc , Raymond James Financial Services Advisors Inc , Institutional Investors Weigh In On Harrow Health , News Ratings For Harrow Health Daily , Harrow Health , Eton Pharmaceuticals Inc , Mendota Financial Group , Virtu Financial , Surface Ophthalmics Inc , Jump Financial , Harrow Health Price Performance , Pharmaceuticals Inc , Get Rating , Financial Group , Raymond James Financial Services Advisors , Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Acuitas Investments LLC Sells 99,708 Shares of Harrow Health, Inc. (NASDAQ:HROW)

Acuitas Investments LLC lowered its position in Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 238,241 shares of the company’s stock after selling 99,708 shares during the period. Harrow Health […] ....

Harrow Health , News Ratings For Harrow Health Daily , Pharmaceuticals Inc , Quarter For Harrow Health , Prelude Capital Management , Wasatch Advisors Inc , Harrow Health Price Performance , Surface Ophthalmics Inc , Acuitas Investments , Blackrock Inc , Eton Pharmaceuticals Inc , Envestnet Asset Management Inc , Securities Exchange Commission , Harrow Health Inc , Get Rating , Asset Management , Capital Management , State Street Corp , Street Corp , Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Visit Holdingschannel , Harrow Health Daily , Nasdaq Hrow ,

Harrow Health (NASDAQ:HROW) Sets New 52-Week High at $25.76

Harrow Health, Inc. (NASDAQ:HROW – Get Rating) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $25.76 and last traded at $25.37, with a volume of 218258 shares trading hands. The stock had previously closed at $24.15. Analyst Upgrades and Downgrades A number of equities analysts have […] ....

Harrow Health , Harrow Health Company Profile , Harrow Health Inc , Surface Ophthalmics Inc , Capital Management , B Riley Financial Inc , Pharmaceuticals Inc , Opaleye Management Inc , News Ratings For Harrow Health Daily , Eton Pharmaceuticals Inc , Harrow Health Price Performance , Portolan Capital Management , Get Rating , Lake Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Harrow Health (NASDAQ:HROW) PT Raised to $37.00

Harrow Health (NASDAQ:HROW – Get Rating) had its price target upped by Lake Street Capital from $24.00 to $37.00 in a research report report published on Monday, The Fly reports. Lake Street Capital currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. B. Riley lifted […] ....

Eton Pharmaceuticals Inc , Pharmaceuticals Inc , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Harrow Health Inc , Hedge Funds Weigh In On Harrow Health , Barclays Plc , Northwestern Mutual Wealth Management Co , Dorsey Wright Associates , Tower Research Capital , Harrow Health Stock Down , Harrow Health , Get Rating , Lake Street Capital , Street Capital , Health Stock Down , Mutual Wealth Management , Research Capital , Captrust Financial Advisors , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Boost Price Target ,

Harrow Health (NASDAQ:HROW) Stock Price Up 4.2%

Harrow Health, Inc. (NASDAQ:HROW – Get Rating)’s stock price shot up 4.2% during trading on Thursday . The stock traded as high as $22.40 and last traded at $22.22. 105,065 shares were traded during mid-day trading, a decline of 70% from the average session volume of 349,277 shares. The stock had previously closed at $21.33. […] ....

Surface Ophthalmics Inc , Harrow Health Inc , Harrow Health , Westside Investment Management Inc , Harrow Health Stock Performance , Pharmaceuticals Inc , Barclays Plc , News Ratings For Harrow Health Daily , Eton Pharmaceuticals Inc , Marshall Wace , Hedge Funds Weigh In On Harrow Health , Northwestern Mutual Wealth Management Co , Get Rating , Street Capital , Investment Management , Northwestern Mutual Wealth Management , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,